JP, put two and two together. It's not hard to fig
Post# of 30028
Posted On: 12/02/2014 7:21:28 PM
JP, put two and two together. It's not hard to figure out. I don't know what Jason's motivation was for posting such lowball revenue estimates, unless perhaps it was to try to draw Gerald into giving realistic estimates.
We know Gerald isn't responding to this question, but he has now stated several times the high likelihood of a diagnostics spinoff, which would certainly include LymPro. Today's presentation has it projected to happen in Q2 2015, and Gerald's comments were by far leading us in that direction, more so than in any prior presentation or call.
It's not unbelievable to me. It's clear to me he's not talking about LymPro revenue because of the ongoing negotiations involving a sale or spinoff. I don't feel there is anything to be concerned about.
But what do I know? Maybe it's just the Kool-Aid I'm drinking. Your drink may cause you to feel differently.
All the best. Exciting times ahead.
We know Gerald isn't responding to this question, but he has now stated several times the high likelihood of a diagnostics spinoff, which would certainly include LymPro. Today's presentation has it projected to happen in Q2 2015, and Gerald's comments were by far leading us in that direction, more so than in any prior presentation or call.
It's not unbelievable to me. It's clear to me he's not talking about LymPro revenue because of the ongoing negotiations involving a sale or spinoff. I don't feel there is anything to be concerned about.
But what do I know? Maybe it's just the Kool-Aid I'm drinking. Your drink may cause you to feel differently.
All the best. Exciting times ahead.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼